Running SV detection tools and benchmarking.

AK Ayse Keskus
AB Asher Bryant
TA Tanveer Ahmad
BY Byunggil Yoo
SA Sergey Aganezov
AG Anton Goretsky
AD Ataberk Donmez
LL Lisa A. Lansdon
IR Isabel Rodriguez
JP Jimin Park
YL Yuelin Liu
XC Xiwen Cui
JG Joshua Gardner
BM Brandy McNulty
SS Samuel Sacco
JS Jyoti Shetty
YZ Yongmei Zhao
BT Bao Tran
GN Giuseppe Narzisi
AH Adrienne Helland
DC Daniel E. Cook
PC Pi-Chuan Chang
AK Alexey Kolesnikov
AC Andrew Carroll
EM Erin K. Molloy
IP Irina Pushel
EG Erin Guest
TP Tomi Pastinen
KS Kishwar Shafin
KM Karen H. Miga
SM Salem Malikic
CD Chi-Ping Day
NR Nicolas Robine
CS Cenk Sahinalp
MD Michael Dean
MF Midhat S. Farooqi
BP Benedict Paten
MK Mikhail Kolmogorov
ask Ask a question
Favorite

Severus (version 0.1.2), SAVANA (version 1.0.3), Manta (version 1.6.0), SvABA (version 1.2.0), and GRIDSS (version2.13.2) followed by GRIPSS (version 2.2) were run with tumor and normal bam pairs using default settings. For Severus, inputs also included a phased vcf described above and tandem repeat annotations file was downloaded from https://github.com/PacificBiosciences/pbsv. “nanomonsv parse” (version 0.6.0) was run with default parameters, and “nanomonsv get was run with --use_racon and --single_bnd options. For Sniffles (version 2.0.7), default settings were used for the normal alignment, while the --non-germline option was used for the tumor alignment. The normal and tumor “snf” output files were merged into a single vcf and parsed for calls only found in the tumor sample. Both tumor and normal Sniffles runs also used the tandem repeats annotation file as an input.

As the GIAB HG002 benchmark was originally designed for the grch37 human reference, we lifted over the benchmarking Tier1 confidence intervals to grch38 and created a ground truth SV set from a curated HG002 assembly (Liao et al. 2023) using hapdiff (Kolmogorov et al. 2023).

For the complex SV analysis Severus (v1.0) was run with ‘--resolve-overlap’ and ‘--single-bp’ parameters for improved clustering.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A